Talk to our Consultant - Intratumoral Cancer Therapy Market

Global Intratumoral Cancer Therapy Market Research Report: Forecast (2023-2028)

By Type (Monoclonal Antibody, Pathogen-Associated Molecular Patterns, Viruses and Plasmids, Cell & Gene Therapies, Small Molecule, Cytokines), By Application (Lung, Breast, Corocteal, Melanoma, Prosta... ... al, Melanoma, Prostate, Others), By End Users (Hospitals & Research Institutes, Clinics), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Company (Amgen Inc., Sirnaomics, Checkmate Pharmaceuticals, Immunovative Therapies, Idera Pharmaceuticals, Daiichi Sankyo, Philogen, Apexigen, Merck, OncoSec Medical Incorporated, DNAtrix, Istari oncology, Nanobiotix, Exicure, Others) Read more

Healthcare
May 2023
Pages 179
Report Format: PDF, Excel, PPT

Market Definition

Intratumoral cancer therapy is a type of cancer treatment in which therapeutic agents are directly injected into the tumor tissue via catheters or implanted devices while avoiding the deterioration of the healthy tissues nearby. This therapy aims to localize & inactivate cancer cells & shrink tumors for improved clinical outcomes for the patient.

Market Insights & Analysis: Global Intratumoral Cancer Therapy Market (2023-28)

The Global Intratumoral Cancer Therapy market is projected to grow at a CAGR of around 11.1% during the forecast period, i.e., 2023-28. The growing prevalence of cancer & rising demand for targeted & personalized medicine for treatment is driving the requirement for this therapy in the market. In addition to this, as the advancement in technology & drug development is transpiring, it has led to the evolution of more precise & effective cancer therapies, which results in the adoption of these therapies by the patients & supports market growth.

Moreover, as the number of cancer patients is rising globally, the need for cancer treatment is enhancing & consumers are becoming more aware of the side effects associated with other cancer therapies, such as chemotherapy & radiation therapy. Therefore, a shift has been observed toward consumer preference for novel cancer treatments, which have fewer side effects & more target effects, driving the demand for this cancer therapy among the end-user in the coming years.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	11.1%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Rest of Asia-Pacific
	South America: Brazil, Rest of South America
	Middle East & Africa: Middle East, Africa
Key Companies Profiled	Amgen Inc., Sirnaomics, Checkmate Pharmaceuticals, Immunovative Therapies, Idera Pharmaceuticals, Daiichi Sankyo, Philogen, Apexigen, Merck, OncoSec Medical Incorporated, DNAtrix, Istari oncology, Nanobiotix, Exicure, Others
Unit Denominations	USD Million/Billion

Additionally, Intratumoral drug delivery is rapidly growing in the field of R&D, with many companies investing in the advancement of novel drug delivery technologies & bringing new and innovative products to market. This has created a lucrative opportunity for the market for this cancer therapy in the forecast year. For instance, in 2022, Merck struck a USD290 million deal with Orion to develop a novel prostate cancer drug.

Moreover, many biotechnology companies are doing mergers & acquisitions to expand, diversify, and strengthen their product portfolio in cancer therapy. For instance, in 2022, Regeneron acquired Checkmate Pharmaceutical, a clinical-stage biopharmaceutical company, & its investigational immune activator for potential use in multiple Tumor Types.

Furthermore, various companies such as OncoSec Medical Incorporated & Intensity Therapeutics are working on developing therapies to treat several cancer diseases like prostrate, breast, etc., which are in the final phases & have the potential to be effective in the treatment in the future, hence augmenting the revenue of the biopharmaceutical company, as well as is predicted to create a potential opportunity for the market growth in the forthcoming period.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Intratumoral Cancer Therapies Market: Background & Evolution
Market Trends & Developments
Global Intratumoral Cancer Therapies Market Dynamics
1. Growth Drivers
2. Challenges
Global Intratumoral Cancer Therapies Government Guidelines
Global Intratumoral Cancer Therapies Recent Developments
1. Marketed Therapy
2. Emerging Therapy
Global Intratumoral Cancer Therapies Market Hotspot & Opportunities
Global Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
    1. Monoclonal Antibody
    2. Pathogen-Associated Molecular Patterns
    3. Viruses and Plasmids
    4. Cell & Gene Therapies
    5. Small Molecule
    6. Cytokines
  2. By Application
    1. Lung
    2. Breast
    3. Corocteal
    4. Melanoma
    5. Prostate
    6. Others (Cervical, Pancreas, etc.)
  3. By End Users
    1. Hospitals & Research Institutes
    2. Clinics
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares & Analysis
North America Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End User
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The United States Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
4. Canada Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
5. Mexico Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
South America Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End User
  4. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
Europe Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End User
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. Germany Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
4. The UK Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
5. France Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
6. Italy Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
7. Spain Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
Middle East & Africa Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End User
  4. By Country
    1. Middle East
    2. Africa
3. Middle East Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
4. Africa Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
Asia-Pacific Intratumoral Cancer Therapies Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End User
  4. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of Asia-Pacific
3. China Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
4. India Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
5. Japan Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
6. South Korea Intratumoral Cancer Therapies Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type
    2. By Application
Global Intratumoral Cancer Therapies Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Research & Development
  4. Strategic Alliances
  5. Strategic Initiatives
2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Amgen Inc.
  2. Sirnaomics
  3. Checkmate Pharmaceuticals
  4. Immunovative Therapies
  5. Idera Pharmaceuticals
  6. Daiichi Sankyo
  7. Philogen
  8. Apexigen
  9. Merck
  10. OncoSec Medical Incorporated
  11. DNAtrix
  12. Istari oncology
  13. Nanobiotix
  14. Exicure
  15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying